T. Rowe Price Investment Management, Inc. Haemonetics Corp Transaction History
T. Rowe Price Investment Management, Inc.
- $151 Billion
- Q1 2025
A detailed history of T. Rowe Price Investment Management, Inc. transactions in Haemonetics Corp stock. As of the latest transaction made, T. Rowe Price Investment Management, Inc. holds 2,195,569 shares of HAE stock, worth $154 Million. This represents 0.09% of its overall portfolio holdings.
Number of Shares
2,195,569
Previous 2,553,814
14.03%
Holding current value
$154 Million
Previous $199 Million
30.03%
% of portfolio
0.09%
Previous 0.12%
Shares
7 transactions
Others Institutions Holding HAE
# of Institutions
351Shares Held
53.3MCall Options Held
417KPut Options Held
314K-
Black Rock Inc. New York, NY5.96MShares$417 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.1MShares$357 Million0.01% of portfolio
-
Neuberger Berman Group LLC New York, NY4.35MShares$304 Million0.24% of portfolio
-
Wellington Management Group LLP Boston, MA2.62MShares$184 Million0.03% of portfolio
-
State Street Corp Boston, MA1.92MShares$134 Million0.01% of portfolio
About HAEMONETICS CORP
- Ticker HAE
- Exchange NYSE
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 51,316,500
- Market Cap $3.59B
- Description
- Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...